---
title: PET/CT imaging of differentiated and medullary thyroid carcinoma using the
  novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE - first clinical experiences
date: '2024-10-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39404789/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241015193456&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our data demonstrate high feasibility of [^(18)F]SiTATE
  PET/CT in a small cohort of patients with MTC and DTC. The use of [^(18)F]SiTATE
  may overcome logistical disadvantages of ^(68)Ga-based tracers and facilitate SSTR-targeted
  PET/CT imaging of thyroid ...'
disable_comments: true
---
CONCLUSION: Our data demonstrate high feasibility of [^(18)F]SiTATE PET/CT in a small cohort of patients with MTC and DTC. The use of [^(18)F]SiTATE may overcome logistical disadvantages of ^(68)Ga-based tracers and facilitate SSTR-targeted PET/CT imaging of thyroid ...